en · de · es · pt
cjc-1295-notes.peptides3081.com › Wiki › Background And Molecular Design — Common Mistakes

Background And Molecular Design — Common Mistakes

By Editorial Desk · published 2026-03-27 · last reviewed 2026-04-29 · Wiki

Everything below concerns RP-HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-04-29. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.

Molecular Background and Naming

The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.

CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.

Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.

Cjc-1295 at a glance

PropertyValueNotes
Molecular weight (no linker)~3.37 kDaCalculated from peptide sequence
Molecular weight (with linker)~3.65 kDaIncludes albumin-binding moiety
AppearanceWhite to off-white powderTypically lyophilized
SolubilitySoluble in waterAlso dissolves in aqueous buffers
Common synonymsModified GRF(1-29), DAC:GRFUsage varies by source

Handling, Stability and Analysis

Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.

Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.

Related pages on this site

CJC-1295 Structure And Mechanism

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Background and Receptor Mechanism

CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.

Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.

At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.

Supporting material

=== Protein folding and first structural models === The study of protein folding began in 1910 with a famous paper by Harriette Chick and C. J. Martin, in which they showed that the flocculation of a protein was composed of two distinct processes: the precipitation of a protein from solution was preceded by another process called denaturation, in which the protein became much less soluble, lost its enzymatic activity and became more chemically reactive. In the mid-1920s, Tim Anson and Alfred Mirsky proposed that denaturation was a reversible process, a correct hypothesis that was initially lampooned by some scientists as "unboiling the egg". Anson also suggested that denaturation was a two-state ("all-or-none") process, in which one fundamental molecular transition resulted in the drastic changes in solubility, enzymatic activity and chemical reactivity; he further noted that the free energy changes upon denaturation were much smaller than those typically involved in chemical reactions. In 1929, Hsien Wu hypothesized that denaturation was protein unfolding, a purely conformational change that resulted in the exposure of amino acid side chains to the solvent. According to this (correct) hypothesis, exposure of aliphatic and reactive side chains to solvent rendered the protein less soluble and more reactive, whereas the loss of a specific conformation caused the loss of enzymatic activity.

== Plasma proteins for clinical use == Many of the proteins in plasma have important therapeutic uses. Albumin is commonly used to replenish and maintain blood volume after traumatic injury, during surgery, and during plasma exchange. Since albumin is the most abundant protein in the plasma its use may be the most well known, but many other proteins, although present in low concentrations, can have important clinical uses. See table below.

=== Angiotensin IV === Amino acid sequence: Arg | Val-Tyr-Ile-His-Pro-Phe Angiotensin IV is a hexapeptide that, like angiotensin III, has some lesser activity. Angiotensin IV has a wide range of activities in the central nervous system. The exact identity of AT4 receptors has not been established. There is evidence that the AT4 receptor is insulin-regulated aminopeptidase (IRAP). There is also evidence that angiotensin IV interacts with the HGF system through the c-Met receptor. Synthetic small molecule analogues of angiotensin IV with the ability to penetrate through blood brain barrier have been developed. The AT4 site may be involved in memory acquisition and recall, as well as blood flow regulation. Angiotensin IV and its analogs may also benefit spatial memory tasks such as object recognition and avoidance (conditioned and passive avoidance). Studies have also shown that the usual biological effects of angiotensin IV on the body are not affected by common AT2 receptor antagonists such as the hypertension medication losartan.

Following the terrorist attacks of September 11, Bush issued an executive order that authorized the President's Surveillance Program. The new directive allowed the National Security Agency to monitor communications between suspected terrorists outside the U.S. and parties within the U.S. without obtaining a warrant, which previously had been required by the Foreign Intelligence Surveillance Act. As of 2009, the other provisions of the program remained highly classified. Once the Department of Justice Office of Legal Counsel questioned its original legal opinion that FISA did not apply in a time of war, the program was subsequently re-authorized by the President on the basis that the warrant requirements of FISA were implicitly superseded by the subsequent passage of the Authorization for Use of Military Force Against Terrorists. The program proved to be controversial; critics of the administration and organizations such as the American Bar Association argued that it was illegal. In August 2006, a U.S. district court judge ruled that the NSA electronic surveillance program was unconstitutional, but on July 6, 2007, the ruling was vacated by the United States Court of Appeals for the Sixth Circuit on the grounds that the plaintiffs lacked standing. On January 17, 2007, Attorney General Alberto Gonzales informed U.S. Senate leaders that the program would not be reauthorized by the President, but would be subjected to judicial oversight.

==== Anesthesia awareness ==== Thiopental is a rapid and effective drug for inducing unconsciousness, since it causes loss of consciousness upon a single circulation through the brain due to its high lipophilicity. Only a few other drugs, such as methohexital, etomidate, or propofol, have the capability to induce anesthesia so rapidly. (Narcotics such as fentanyl are inadequate as induction agents for anesthesia.) Supporters argue that since the thiopental is given at a much higher dose than for medically induced coma protocols, it is effectively impossible for the condemned to wake up. Anesthesia awareness occurs when general anesthesia is inadequately maintained, for a number of reasons. Typically, anesthesia is 'induced' with an intravenous drug but 'maintained' with an inhaled anesthetic given by the anesthesiologist or nurse-anesthetist (note that there are several other methods for safely and effectively maintaining anesthesia). Barbiturates are used only for induction of anesthesia, and although these drugs rapidly and reliably induce anesthesia, they wear off quickly. A neuromuscular-blocking drug may then be given to cause paralysis, which facilitates intubation, although this is not always required. The anesthesiologist or nurse anesthetist is responsible for ensuring that the maintenance technique (typically inhalational) is started soon after induction to prevent the patient from waking up. General anesthesia is not maintained with barbiturate drugs because they are so short-acting.

Sources: en.wikipedia.org

Supporting material

=== Speciality style ciders === Speciality style ciders are open to a lot more manipulation than modern or heritage style ciders. There is no restriction to apple varieties used and the list of speciality styles continues to expand. Listed on the USACM Cider Style Guide, speciality styles include: fruit, hopped, spiced, wood-aged, sour, and iced ciders. Fruit ciders have other fruit or juices added before or after fermentation, such as cherries, blueberries and cranberries. Hopped cider is fermented with added hops, common hop varieties being Cascade, Citra, Galaxy, and Mosaic. Spiced ciders have various spices added to the cider before, during, or after fermentation. Spices like cinnamon and ginger are popular to use in production. Wood-aged ciders are ciders that are either fermented or aged in various types of wood barrels, to aid in extraction of woody, earthy flavours. Sour ciders are high acid ciders that are produced with non-standard, non-Saccharomyces yeast and bacteria, which enhance acetic and lactic acid production, to reach a sour profile. Ice ciders can be made by using pre-pressed frozen juice or frozen whole apples. Whole apples either come frozen from the orchard, dependent on harvest date, or are stored in a freezer prior to pressing. When the pre-pressed juice or whole apples freeze, sugars are concentrated and mostly separated from the water. Whole apples are then pressed to extract the concentrated juice. For the pre-pressed juice the concentrated solution is drawn off while thawing occurs.

== Early life == Arsène Charles Ernest Wenger was born on 22 October 1949 in Strasbourg, Bas-Rhin, the youngest of three children born to Alphonse and Louise Wenger. He lived in Duppigheim during the 1950s, but spent most of his time in the neighbouring village of Duttlenheim, 16 km (10 miles) south-west of Strasbourg. Arsène's father, Alphonse, like many Alsatians, was conscripted into the German Army by force following Germany's earlier annexation of the French region of Alsace-Lorraine. He was sent to fight on the Eastern Front in October 1944, at the age of 24. The Wenger family owned an automobile spare parts business and a bistro named La Croix d'Or. In his book, My Life in Red and White, Wenger says the "alcohol, brawling and violence" of the bistro's patrons sparked his early interest in human psychology. His parents had difficulty looking after their children, but Duttlenheim was a village where everyone took care of the young; Wenger compared it in later years to a kibbutz. Before Wenger started school, he expressed himself in the local Alsatian dialect of Low Alemannic German. The primary school which Wenger attended was run by the Catholic Church, and as one of its brightest students, he later was accepted into a secondary school in Obernai. According to his father, who also managed the village team, Wenger was introduced to football "at about the age of six". He was taken to games in Germany, where he held an affection for Borussia Mönchengladbach.

=== Dissolution and UN embargo === During the collapse of communism in Europe, Yugoslavia's republics introduced multiparty politics and held elections in 1990. During the same time, conflicts between the republics and the national communities intensified and federal institutions weakened. Just weeks after the first Croatian elections and after a Dinamo Zagreb-Red Star riot at the same stadium, at the Yugoslavia-Netherlands friendly in preparation for the 1990 World Cup, the Croatian crowd in Zagreb jeered the Yugoslav team and anthem and waved Dutch flags (owing to its resemblance to the Croatian tricolour). With the dissolution of Yugoslavia, the team split up and players joined the newly emerging national teams. The Belgrade-based team of the Federal Republic of Yugoslavia (FRY) was banned from competing at Euro 92 under UN sanctions. The decision was made on 31 May 1992, just 10 days before the competition commenced. The SFRY Yugoslav team had earned the top spot of their group during the disintegration, and the FRY team was unable to take its spot in the competition due to United Nations Security Council Resolution 757. Their place was taken by group runners-up Denmark, who went on to win the competition. After the breakup of Yugoslavia, Serbia and Montenegro proclaimed the state of FRY, which claimed to be the continuation of the previous Yugoslavia. A claim which was not generally accepted by the international community, except by FIFA and UEFA.

== Mechanism == Cilostazol is a selective inhibitor of phosphodiesterase type 3 (PDE3) with therapeutic focus on increasing cAMP. An increase in cAMP results in an increase in the active form of protein kinase A (PKA), which is directly related with an inhibition in platelet aggregation. PKA also prevents the activation of an enzyme (myosin light-chain kinase) that is important in the contraction of smooth muscle cells, thereby exerting its vasodilatory effect.

Sources: en.wikipedia.org

Notes from published material

Portugal's manufacturing industry accounted for 21.2% of the country's total GDP as of 2024, down from an annual average of 26% over the period between 1953 and 1973. The lower contribution of manufacturing to Portugal's economy has led to lower real GDP growth rates between 1974 and 2019 than during the period between 1950 and 1973. As of 2025, Portugal's automobile industry produced the biggest share of the country's exports. The automobile industry accounts for 20.2% of the country manufacturing exports and 82.8% of the total value of its exports employing 43.247 workers in 2020. Portugal's service sector accounted for 76.5% of the country's total economic output as of 2024. Tourism, retail, and telecommunication are all major industries. Tourism represented 11.8% of the Portugal's total GDP as of 2025. Portugal attracted nearly 30 million international tourists in 2025, ranking 15th in the world in that year for inbound tourism.

== Uses == Fritillaria extracts are used in traditional Chinese medicine under the name chuan bei mu, and in Latin, bulbus fritillariae cirrhosae. The bulbs of Fritillaria roylei have been used as antipyretics and expectorants. Lilium bulbs, particularly Lanzhou lily (Lilium davidii) are used as food in China and other parts of Asia. Calochortus bulbs were eaten by Native Americans and as a famine food by Mormon settlers. During World War II, starvation conditions in the Netherlands (Hongerwinter, hunger winter 1944) led to Tulipa bulbs being used as food. Other members of the family used for food include Clintonia (leaves), Medeola (roots), Erythronium (corms), and Fritillaria (bulbs).

Congenital myopathy is a very broad term for any muscle disorder present at birth. This defect primarily affects skeletal muscle fibres and causes muscular weakness and/or hypotonia. Congenital myopathies account for one of the top neuromuscular disorders in the world today, comprising approximately 6 in 100,000 live births every year. As a whole, congenital myopathies can be broadly classified as follows:

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 a natural hormone?

No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.

Why do two versions share one name?

Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.

What is the relationship to GRF(1-29)?

The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.

Why is mass spectrometry used alongside chromatography?

Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.

Network